FDA Withdraws Approval of New Animal Drug Applications for Ketamine, S-Methoprene, and Nitazoxanide

Summary

The US Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADAs) and an abbreviated new animal drug application (ANADA) for the veterinary use of ketamine, S-methoprene, and nitazoxanide, as part of an amendment to the animal drug regulations.